Potential of curcumin-loaded cubosomes for topical treatment of cervical cancer


Loading...

Date

2022-08-15

Publication Type

Journal Article

ETH Bibliography

yes

Citations

Altmetric

Data

Abstract

Cervical cancer is one of the most common cancers affecting women worldwide. There are an estimated 570.000 new cases of cervical cancer each year and conventional treatments can cause severe side effects. In this work, we developed a platform for vaginal administration of lipophilic drugs for cervical cancer treatment. We formulated mucoadhesive cubosomes for the delivery of curcumin, a lipophilic drug for cervical cancer treatment, to increase its bioavailability and local absorption. This study tests the use of cubosomes for vaginal drug administration and assesses their potential efficiency using the CAM (chick embryo chorioallantoic membrane) model. SAXS (small-angle X-ray scattering), cryo-TEM (cryo-transmission electron microscopy), and dynamic light scattering (DLS) were employed to characterise the system. With ex vivo permeation and retention studies, we find that the curcumin released from our system is retained in the vaginal mucosa. In vitro cytotoxicity assay and cellular uptake showed an increased cytotoxic effect of curcumin against HeLa cell line when incorporated into the cubosomes. The curcumin-loaded cubosomes also demonstrated an antiangiogenic effect evaluated in vivo by the CAM model.

Publication status

published

Editor

Book title

Volume

620

Pages / Article No.

419 - 430

Publisher

Elsevier

Event

Edition / version

Methods

Software

Geographic location

Date collected

Date created

Subject

Cubosomes; DOTAP; Mucoadhesion; Vaginal administration; Cervical cancer; Chorioallantoic membrane model

Organisational unit

02891 - ScopeM / ScopeM check_circle
03857 - Mezzenga, Raffaele / Mezzenga, Raffaele check_circle

Notes

Funding

Related publications and datasets